Call for Abstract
14th International Conference on Clinical & Experimental Cardiology, will be organized around the theme “The Science of Heart Discovery”
Cardiology 2016 is comprised of 14 tracks and 120 sessions designed to offer comprehensive sessions that address current issues in Cardiology 2016.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Cardiovascular Medicine
- Track 1-2Modern practices in cardiovascular therapy
- Track 1-3Cardiac progenitor cells
- Track 1-4Percutaneous Coronary Intervention (PCI)
- Track 1-5Hypertension for the primary care clinician
Heart failure is a condition caused by the heart failing to pump enough blood around the body at the right pressure. It usually occurs because the heart muscle has become too weak or stiff to work properly. If you have heart failure, it does not mean your heart is about to stop working. It means the heart needs some support to do its job, usually in the form of medicines. Breathlessness, feeling very tired and ankle swelling is the main symptoms of heart failure. But all of these symptoms can have other causes, only some of which are serious. The symptoms of heart failure can develop quickly (acute heart failure). If this happens, you will need to be treated in hospital. But they can also develop gradually (chronic heart failure). The most common causes are heart attack, high blood pressure, cardiomyopathy (diseases of the heart muscle. Sometimes these are inherited from your family and sometimes they are caused by other things, such as viral infections).
- Track 2-1Exercise physiology in heart failure
- Track 2-2Cardiac pacing strategies in heart failure
- Track 2-3Neurohumoral, immunologic and cytokine aspects of heart failure
- Track 2-4Pulmonary circulation aspects, pulmonary hypertension
- Track 2-5Predictors and markers of heart failure outcome
- Track 2-6Beta-blockers and beta-adrenergic receptors in heart failure
- Track 2-7Left ventricular hypertrophy and hypertrophic cardiomyopathy
- Track 2-8Heart rhythm and miscellaneous cardiology topics
Heart disease meetings include heart diseases that is any type of disorder that affects the heart. Heart disease meetings comes under cardiology conferences that comprises the heart diseases tracks that means the same as cardiac disease but not the cardiovascular diseases. This condition results from a buildup of plaque on the inside of the arteries, which reduces blood flow to the heart and increases the risk of a heart attack and other heart complications. In this sub topic Heart disease we have different types of heart diseases i.e. Coronary heart diseases, Pediatric heart diseases, Congenital Heart Diseases, myocardial infarction etc.
- Track 3-1Coronary heart disease and vasospasm, atherothrombotic disease
- Track 3-2Cardio myopathy and arteriosclerotic vascular disease
- Track 3-3Myocardial infarction and arrhythmias
- Track 3-4Inflammatory heart disease, hypertension
- Track 3-5Cardiovascular diseases in women
- Track 3-6Pediatric heart diseases
- Track 3-7Innovation in ischemic heart disease, angiogenesis
- Track 3-8Epidemiological transition of cardiovascular disease
People with a body mass index (BMI) of 30 or higher are considered obese. The term obesity is used to describe the health condition of anyone significantly above his or her ideal healthy weight. Obesity increases the risk for heart disease and stroke. But it harms more than just the heart and blood vessel system. It's also a major cause of gallstones, osteoarthritis and respiratory problems. Obesity is intimately intertwined with multiple health conditions that underlie cardiovascular disease including high blood pressure, diabetes, and abnormal blood cholesterol. In addition, weight gain is a frequent consequence of heart-damaging lifestyle choices such as lack of exercise and a fat-laden diet. Obesity also can lead to heart failure. This is a serious condition in which your heart can't pump enough blood to meet your body's needs.
- Track 4-1Blood Pressure
- Track 4-2Obesity and the Heart
- Track 4-3Sleep Apnea
- Track 4-4Ischemic heart disease
- Track 4-5Hypertensive heart disease
- Track 4-6Cardiac dysrhythmias
- Track 4-7Congenital heart disease
- Track 4-8Heart attack
- Track 4-9Coronary heart disease
- Track 4-10Benefits of Weight loss on Cardiovascular Health
- Track 4-11Bariatric Surgery and Cardiovascular Risk
- Track 4-12Overweight and Obesity
Cardiology conferences includes the Cardiac Drugs which are used in any way to treat conditions of the heart or the circulatory or vascular system. Many classes of cardiovascular agents are available to treat the various cardiovascular conditions. They are a complicated group of drugs with many being used for multiple heart conditions. Prescription drugs and medicines for diseases relating to the structure and function of the heart and blood vessels. In this sub topic we have Sodium, potassium, calcium channel blockers, ACE-inhibitors and Cardiac biomarkers. There are 6 associations and societies and the main association for Cardiac Therapeutic Agents in USA. 50 universities are working on Cardiac Therapeutic Agents. There are 120 Companies in USA that are making Cardiac Therapeutic Agents in Cardiology. 3new drugs were introduced in 2015. There are many types of cardiovascular drugs in the market that include Cardiac glycosides, antiarrhythmic agents, antianginal agents and antihypertensive agents.
- Track 5-1Sodium, potassium, calcium channel blockers
- Track 5-2Beta blockers, mitral valve prolapse
- Track 5-3ACE-inhibitors, left ventricular remodeling and hypertrophy
- Track 5-4ARB-antagonists, renin-angiotensin system
- Track 5-5Cardiac biomarkers, cardiac tests and assessment of coronary reperfusion
Advances in imaging technology have sparked fundamental changes in the approach to cardiac care. One of the most accurate diagnostic techniques cardiac imaging employs new, non-invasive and minimally invasive radiology technology to produce three-dimensional images of the heart. The imaging tools help to discover medical problems that several years ago were undetectable using conventional methods of diagnosis. Cardiac imaging techniques include coronary catheterization, echocardiogram, and intravascular ultrasound.
- Track 6-1State of the art cardiovascular imaging
- Track 6-2Latest advances in cardiovascular imaging
- Track 6-3Imaging of coronary atherosclerosis
- Track 6-4Coronary catheterization
- Track 6-5Echocardiogram
- Track 6-6Intravascular ultrasound
Cardiovascular disease (CVD) heart disease and stroke is the biggest killer of women globally, killing more women than all cancers, tuberculosis, HIV/AIDS and malaria combined. Heart disease is the leading cause of death for women in the United States, killing 292,188 women in 2009 that’s 1 in every 4 female deaths. While some women have no symptoms, others experience angina (dull, heavy to sharp chest pain or discomfort), pain in the neck/jaw/throat or pain in the upper abdomen or back. These may occur during rest, begin during physical activity, or be triggered by mental stress. Sometimes heart disease may be silent and not diagnosed until a woman experiences signs or symptoms of a heart attack, heart failure, an arrhythmia or stroke. Women with diabetes have higher CVD mortality rates than men with diabetes. Women who engage in physical activity for less than an hour per week have 1.48 times the risk of developing coronary heart disease, compared to women who do more than three hours of physical activity per week. Go Red for Women is a major international awareness campaign dedicated to the prevention, diagnosis and control of heart disease and stroke in women.
- Track 7-1Cardiovascular diseases in pregnancy
- Track 7-2Transforming cardiovascular prevention for women: Time for the pygmalion construct to end
- Track 7-3Diagnostic pathways to identify significant cad & female specific risk
Pediatric Cardiology is responsible for the diagnosis of congenital heart defects, performing diagnostic procedures such as echocardiograms, cardiac catheterizations, and for the ongoing management of the sequel of heart disease in infants, children and adolescents. The division is actively involved in research aimed at preventing both congenital and acquired heart disease in children. Finally, the division is committed to educating the next generation of physicians, and offers advanced training in pediatric cardiology.
- Track 8-1Pediatric heart physiology
- Track 8-2Pediatric heart catheterization
- Track 8-3Children and adolescents: Prehypertension and metabolic syndrome, progression of risk and diagnosis of disease
- Track 8-4Pediatric angina
- Track 8-5Pediatric diseases pathology
- Track 8-6Pediatric heart transplant
- Track 8-7Pediatric Cardiologists
Cardiac nursing is a nursing specialty that works with patients who suffer from various conditions of the cardiovascular system. Cardiac nurses help treat conditions such as unstable angina, cardiomyopathy, coronary artery disease, congestive heart failure, myocardial infarction and cardiac dysrhythmia under the direction of a cardiologist. Cardiac nurses perform postoperative care on a surgical unit, stress test evaluations, cardiac monitoring, vascular monitoring, and health assessments. Cardiac nurses work in many different environments, including coronary care units (CCU), cardiac catheterization, intensive care units (ICU), operating theatres, cardiac rehabilitation centers, clinical research, cardiac surgery wards, cardiovascular intensive care units (CVICU), and cardiac medical wards.
- Track 9-1Cardiac Surgery Nursing
- Track 9-2Cardiac Care
- Track 9-3Cardiovascular Nursing
- Track 9-4Cardiac Registered Nursing (RN)
- Track 9-5Pediatric Cardiac Nursing
The term diabetic heart disease (DHD) refers to heart disease that develops in people who have diabetes. Diabetes is a disease in which the body's blood glucose (sugar) level is too high. Normally, the body breaks down food into glucose and carries it to cells throughout the body. The cells use a hormone called insulin to turn the glucose into energy. There is a clear-cut relationship between diabetes and cardiovascular disease. Coronary heart disease is recognized to be the cause of death for 80% of people with diabetes; however, the NHS states that heart attacks are largely preventable. Cardiovascular disease is the leading cause of mortality for people with diabetes. Hypertension, abnormal blood lipids and obesity, all risk factors in their own right for cardiovascular disease, occur more frequently in people with diabetes. Several advances in treating heart disease over the past two decades have improved the chances of surviving a heart attack or stroke. However, as the incidence of diabetes steadily increases, so does the number of new cases of heart disease and cardiovascular complications.
- Track 10-1Diabetic cardiomyopathy
- Track 10-2Cerebrovascular diseases (stroke)
- Track 10-3Diabetes and stroke
- Track 10-4Diabetes and peripheral arterial disease
- Track 10-5Diabetes and peripheral arterial disease
- Track 10-6Renal Disease
- Track 10-7Diabetes and Blood Pressure
- Track 10-8Diabetes & Cholesterol
- Track 10-9Diabetes and Heart Diseases
Cardiovascular surgery is surgery on the heart or great vessels performed by cardiac surgeons. Frequently, it is done to treat complications of ischemic heart disease (for example, coronary artery bypass grafting), correct congenital heart disease, or treat valvular heart disease from various causes including endocarditis, rheumatic heart disease and atherosclerosis. It also includes heart transplantation. The development of cardiac surgery and cardiopulmonary bypass techniques has reduced the mortality rates of these surgeries to relatively low ranks. Coronary artery bypass grafting (CABG) is the most common type of heart surgery. CABG improves blood flow to the heart. Surgeons use CABG to treat people who have severe coronary heart disease (CHD).
- Track 11-1Open Heart Surgery
- Track 11-2Cardiomyopathies
- Track 11-3Adult congenital heart disease and sports cardiology
- Track 11-4Cardiac transplantation
- Track 11-5Surgery for lv dysfunction
- Track 11-6Mechanical support left ventricular assist devices
- Track 11-7Therapeutic and physiologic issues surrounding heart valve surgery
- Track 11-8Angioplasty or surgery for multivessel coronary artery disease
- Track 11-9Advances in congenital heart disease
- Track 11-10Transmyocardial Revascularization (TMR)
- Track 11-11Stent Procedure
- Track 11-12Minimally Invasive Heart Surgery
- Track 11-13Heart Transplant
- Track 11-14Cardiomyoplasty
- Track 11-15Bypass Surgery
- Track 11-16Artificial Heart Valve Surgery
- Track 11-17Angioplasty
- Track 11-18Interventional cardiology
Advances in medicine means that if CHD is detected at an early stage it can be treated successfully to extend the survival rate. Successful treatment is more likely if the disease is detected at its earliest stages. Our current research focuses on the early detection of CHD in order to halt or reverse the progress of the disease. The ongoing research includes pioneering the use of heart scanning in the early diagnosis of heart disease in diabetics, Development of Nuclear Cardiology techniques for the detection of heart disease, Drug development and evaluation of treatments used in heart disease, Identification of novel biological markers to predict the presence of heart disease, Analysis of ethnic and socio-economic differences in heart disease risk.
- Track 12-1Vitamin D intake and the risk of heart disease
- Track 12-2Cardiopulmonary resuscitation
- Track 12-3Cardiac rehabilitation
- Track 12-4Prosthetic heart valves and associated complications
- Track 12-5Pacemakers and implantable defibrillators: New developments
- Track 12-6Thrombolytic therapy in stroke
- Track 12-7Mental stress and its gender-specific link to coronary diseases
- Track 12-8Statin therapy for prevention of heart diseases
- Track 12-9Influence of diet and gut flora on cardiovascular diseases
- Track 12-10Cardiac stem cells